Procter & Gamble Health Ltd - 500126 - Shareholder Meeting / Postal Ballot-Outcome of AGM
We would like to inform you that the 53rd Annual General Meeting of the Company was held on November 26, 2020 at 3.30 p.m. through Video Conference / Other Audio Visual Means. In this respect, please find enclosed a summary of proceedings of the 53rd Annual General Meeting. Procter & Gamble Health Ltd - 500126 - Shareholder Meeting / Postal Ballot-Outcome of AGM
We would like to inform you that the 53rd Annual General Meeting of the Company was held on November 26, 2020 at 3.30 p.m. through Video Conference / Other Audio Visual Means. In this respect, please find enclosed a summary of proceedings of the 53rd Annual General Meeting. Procter & Gamble Health Ltd - 500126 - Unaudited Financial Results For The Quarter Ended September 30, 2020
We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended September 30, 2020 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended September 30, 2020; b. Press Release; and c. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended September 30, 2020 furnished by Statutory Auditors of the Company. Kindly take the same on record and oblige. Procter & Gamble Health Ltd - 500126 - Unaudited Financial Results For The Quarter Ended September 30, 2020
We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended September 30, 2020 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended September 30, 2020; b. Press Release; and c. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended September 30, 2020 furnished by Statutory Auditors of the Company. Kindly take the same on record and oblige. Procter & Gamble Health Ltd - 500126 - Reg. 34 (1) Annual Report
We refer to our letter dated September 28, 2020, informing the date of 53rd Annual General Meeting. In this respect, please find enclosed Annual Report for the Financial Year ended June 30, 2020 and Notice calling the 53rd Annual General Meeting of the Company. Merck says early data from Covid-19 vaccines expected this year
Initial data showing whether V591 triggers an immune response in trial participants is expected by the end of the year Procter & Gamble Health Ltd - 500126 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter Ended September 30, 2020
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2020 ,inter alia, to consider and approve the unaudited financial results for the quarter ended September 30, 2020. COVID-19: Merck, Serum Institute, IAVI, Scripps Research join hands to develop monoclonal antibodies
Serum Institute of India (SII) has teamed up with Merck KGaA, Germany, to develop COVID-19 fighting monoclonal antibodies (mAbs), made by cloning a unique white blood cell to increase immunity and fight diseases, along with drug research driven nonprofit scientific research organization IAVI and Scripps Research Procter & Gamble Health Ltd - 500126 - Shareholding for the Period Ended September 30, 2020
Procter & Gamble Health Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here Procter & Gamble Health Ltd - 500126 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith Certificate under Regulation 74(5) SEBI (Depositories and Participants) Regulations, 2018 for the period July-September 2020.